Mr. Speaker, it is a bit hard for me to say everything I want to say with the right words in French, so I will switch to English.
The specific terminology is a bit difficult, at least for me, in French.
What we know is that genetic information is going to be more important. Partly, we have to consider that in the context of screening large portions of the population. It could interfere with things such as getting insurance if one knew one was at greater risk than the general population, so we have to look at that very carefully.
It will be very important as time goes on to know that certain cancers are linked together, such as colon cancer, ovarian cancer and breast cancer. The more knowledge Canadians have, the better the informed choice they will be able to make, rather than having to rely on their own decision-making.